Table 6 Log-likelihood ratio tests for each regression nested model showed in Tables 3, 4 and 5
From: Healthcare cost expenditures associated to frailty and sarcopenia
Cross-sectional analysis | At follow-up | |||
|---|---|---|---|---|
Frailty measured with the Frailty Index | Frailty measured with the FTS5 | Frailty measured with the Frailty Index | Frailty measured with the FTS5 | |
Regression results from Table 3 | ||||
M2 vs M1 | 359.82*** | 288.96*** | ||
M3 vs M2 | 318.80*** | 323.05*** | 294.07*** | 255.98** |
M4 vs M3 | 358.93*** | 367.01*** | 287.63*** | 299.02*** |
Regression results from Table 4 | ||||
M2 vs M1 | 263.48*** | 269.01*** | 270.07*** | 277.27*** |
M3 vs M2 | 272.31*** | 281.09*** | 286.12*** | 292.37*** |
M4 vs M3 | 288.82*** | 295.72*** | 290.69*** | 297.99*** |
Regression results from Table 5 | ||||
M2 vs M1 | 301.98*** | 321.14*** | 318.68*** | 326.79*** |
M3 vs M2 | 310.45*** | 333.37*** | 335.09*** | 341.20*** |